More than 90% of the time, renal artery stenosis is caused by atherosclerosis, a process in which plaque made up of fats, cholesterol, and other materials builds up on the walls of the blood vessels, ...

Recent trials of percutaneous revascularization for the treatment of renal artery stenosis have been disappointing. In many cases, essential hypertension coexists with the presence of renal artery ...

There is no published evidence directly comparing angioplasty with stent placement and "aggressive" medical treatment with currently available drugs for ARAS (See Table A). Therefore, this review ...

Approval Supported by the HERCULES Study, Which Demonstrated that Renal Stenting with RX Herculink Elite® is Safe and Significantly Reduces Blood Pressure at Nine Months ABBOTT PARK, Ill., Aug. 10, ...

An interventional cardiologist and two nephrologists debate the issue at a major medical conference. ORLANDO—More than 30,000 Americans with atherosclerotic renovascular disease (ARVD) undergo ...

There is always great excitement in the blood pressure clinic when we encounter a patient with renal artery stenosis. In the majority this is due to atheromatous renal artery stenosis (ARAS). Some of ...

[In relatively asymptomatic patients] revascularization ... seems to offer no benefits over medical treatment... Atherosclerotic renal artery stenosis is associated with cardiovascular disease and a ...

The body's cardiovascular system ensures that oxygen -- and nutrient-rich blood reaches each organ in order for them to function properly. When renal artery stenosis (RAS) occurs, not only does ...

In their study published in 1988, Pickering et al 1 described a group of patients with recurrent pulmonary edema and hypertension due to renal artery stenosis treated with renal revascularization.

The term renal artery stenosis (RAS) applies to a cluster of disease conditions with varying etiologies. The most prominent among them are fibromuscular dysplasia and atherosclerotic RAS (ARAS). Renal ...

Abbott Park, Illinois — Abbott today announced it has received U.S. Food and Drug Administration (FDA) approval for the RX Herculink Elite® Renal Stent System for the treatment of renal artery ...

THE appreciation of renal-artery lesions as a cause of systemic hypertension began with the work of Goldblatt et al. 1 in 1934. This experimental finding was immediately implicated in human ...